Crossmark

Adjunctive serial post-operative intravitreal methotrexate injections in the management of advanced proliferative vitreoretinopathy

Published Online: 2021-04-26

Published Print: 2021-10

Authors

Roca, José A.

Yon-Mendoza, Analí

Huamán, Nathaly

Wu, Lihteh https://orcid.org/0000-0002-3387-7058
License Information

Text and Data Mining valid from 2021-04-26

Version of Record valid from 2021-04-26
More Information

Article History

Received: 1 December 2020

Revised: 3 April 2021

Accepted: 19 April 2021

First Online: 26 April 2021

Declarations

:

: IRB approval was obtained from the Clinica Ricardo Palma IRB, Lima, Perú. Individual informed consent was obtained for the surgical treatment of the disease and the off-label use of intravitreal MTX. The study and data collection were performed in adherence to the tenets of the Declaration of Helsinki.

: Dr. Wu has received lecture fees from Bayer and Quantel Medical. Drs Roca, Yon-Mendoza, and Huaman declare that they do not have any financial interest.

Document is current